Latest Prescription Drugs news
Posoleucel Efficacious for Stem Cell Transplant Recipients
posted January 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
posted January 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Racial/Ethnic Minorities Less Likely to Use Newer Antiseizure Meds
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
